| (210) | Number of the EPO application | 15865103 |
| (220) | Filing date of the EPO application | 2015.12.03 |
| (80) | EPO patent specification publication (B) | EPB nr. 13/2024, 2024.03.27 |
| (110) | EPO patent number | 3226887 |
| (21) | Number of the application | e 2017 0160 |
| (71) | Name(s) of applicant(s), code of the country | ACCELERON PHARMA INC., US; |
| (72) | Name(s) of inventor(s), code of the country | ATTIE Kenneth M., US;
ROVALDI Christopher Robert, US; |
| (73) | Name(s) of owner(s), code of the country | ACCELERON PHARMA INC., US; |
| (54) | Title of the invention | ACTRIIB POLYPEPTIDES FOR USE IN THE TREATMENT SIDEROBLASTIC ANEMIA |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 35/18 (2015.01.01); A61K 38/18 (2006.01.01); A61K 35/14 (2015.01.01); A61K 38/17 (2006.01.01); A61K 39/395 (2006.01.01); C07K 14/495 (2006.01.01); C07K 14/71 (2006.01.01); C12Q 1/6883 (2018.01.01); A61P 7/00 (2006.01.01); A61P 7/06 (2006.01.01); A61P 35/02 (2006.01.01); A61P 43/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2017.12.31 |
| (30) | Priority | 201462086977 P, 2014.12.03, US; 201462088087 P, 2014.12.05, US; 201562155395 P, 2015.04.30, US |
| (86) | International application | PCT/US2015/063835, 2015.12.03 |
| (87) | International publication | WO 2016/090188, 2016.06.09 |